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AMPA Receptor-Dependent Clustering of Synaptic
NMDA Receptors Is Mediated by Stargazin and NR2A/B
in Spinal Neurons and Hippocampal Interneurons
spines, such as hippocampal pyramidal neurons (Mi et
al., 2002). These mechanistic differences mirror the dis-
tribution of the immediate early gene product Narp,
which has been proposed to play a role in aggregating
the AMPA class of glutamate receptors at excitatory
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NMDA receptors and the transmembrane coupling mol-Summary
ecule stargazin then draws AMPA receptors to these
synapses. Stargazin is a critical link because it interactsUnder standard conditions, cultured ventral spinal
with AMPA-type glutamate receptors via one domainneurons cluster AMPA- but not NMDA-type glutamate
and interacts with the MAGUK class of cytoplasmic an-receptors at excitatory synapses on their dendritic
choring molecules, such as PSD-95, at another site.shafts in spite of abundant expression of the ubiqui-
The interaction between MAGUK proteins and stargazintous NMDA receptor subunit NR1. We demonstrate
occurs through the C-terminal tail of stargazin, whichhere that the NMDA receptor subunits NR2A and NR2B
contains a PDZ binding site (Chen et al., 2000; Schnellare not routinely expressed in cultured spinal neurons
et al., 2002; Tomita et al., 2003). Similar sites are alsoand that transfection with NR2A or NR2B reconstitutes
present on the C terminus of NR2 subunits, which alsothe synaptic targeting of NMDA receptors and confers
interact with MAGUK proteins.on exogenous application of the immediate early gene
A challenge to the central role of NMDA receptors inproduct Narp the ability to cluster both AMPA and
synaptic glutamate receptor targeting was first revealedNMDA receptors. The use of dominant-negative mu-
in animals without NMDA receptors that have retainedtants of GluR2 further showed that the synaptic targeting
synaptic AMPA receptors (Tsien et al., 1996), as well asof NMDA receptors is dependent on the presence of
in work recently described in hippocampal interneuronssynaptic AMPA receptors and that synaptic AMPA and
(Nyiri et al., 2003), which shows significant variability inNMDA receptors are linked by Stargazin and a MAGUK
synaptic NMDA receptor clustering in spite of a more
protein. This system of AMPA receptor-dependent syn-
uniform synaptic AMPA receptor expression.
aptic NMDA receptor localization was preserved in In cultured spinal neurons, which have a robust,
hippocampal interneurons but reversed in hippocam- Gaussian distribution of AMPA receptors at excitatory
pal pyramidal neurons. synapses, little synaptic NMDA receptor clustering is
noted (O’Brien et al., 1997, 1998). The preferential clus-
Introduction tering of AMPA receptors at spinal synapses in vitro
occurs in spite of robust expression of the ubiquitous
The molecular mechanisms governing the formation of NMDA receptor subunit NR1 (Mi et al., 2002) and a che-
excitatory synapses in the central nervous system are mosensitivity to exogenous NMDA that is equivalent to
the subject of intense and increasingly detailed investi- that of cultured hippocampal neurons that have synaptic
gation (Goda and Davis, 2003). Previously, we proposed NMDA receptors (O’Brien et al., 1997). Chimeric cultures
that the mechanisms governing the formation of gluta- of hippocampal and spinal neurons indicate that the
matergic synapses on neurons that receive excitatory lack of synaptic NMDA receptor clustering in spinal neu-
synapses directly onto their dendritic shafts, such as rons is due to a lack of expression of one or more pro-
spinal cord neurons and hippocampal interneurons, dif- teins by the postsynaptic spinal neurons rather than to
fered significantly from those that govern the formation the lack of a necessary presynaptic organizing molecule
of excitatory synapses on neurons that have dendritic (Mi et al., 2002).
In this paper, we show that cultured spinal neurons
under basal conditions lack the expression of the NMDA*Correspondence: robrien@jhmi.edu
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Figure 1. NMDA Receptor Clustering in Ventral Spinal Neurons
(A) High-density cultures of hippocampal or ventral spinal neurons were grown at a similar density for 12 days in vitro. Cultures were solublized
in equal volumes of M-Per plus protease inhibitors (200,000 cells/ml) and run on SDS PAGE and probed with the indicated antibodies. All
experiments were done in triplicate and yielded similar results. In (B)–(I), 12 day cultures of hippocampal and ventral spinal neurons were
immunostained with the indicated antibodies showing (synaptic) clusters of NR1 (B) and NR2A (C) in hippocampal neurons but not in spinal
neurons (F and G). PSD-95 (D and H) and Chapsyn-110 (E and I) showed synaptic clustering in both (calibration bar, 10 m). The high molecular
weight band seen with the NR2C antibody in hippocampal cultures represents a cross-reacting NR2A or NR2B epitope and is absent in spinal
cultures which lack NR2A or NR2B.
receptor subunits NR2A and NR2B. Synaptic targeting ference in expression of NR2A and NR2B was seen either
with antibodies to the interior portion of the C-terminal tailof endogenous NR1 in spinal neurons can be reconstitu-
ted by transfection with either NR2A or NR2B and re- (shown) or with antibodies to the extreme C terminus (not
shown). The deficit in NR2A and NR2B expression andquires a linkage to preexisting synaptic AMPA receptors,
independent of additional presynaptic targeting mole- the lack of synaptic NMDA receptors in spinal neurons
was present both at 1 week and 2 weeks in vitro (Figurecules. This linkage requires stargazin and a MAGUK
protein, although additional NR2-mediated interactions 1F; see also Figure 5), while in hippocampal neurons,
synaptic NMDA receptors (Figure 1B) and NR2A andare also likely. This mechanism of synaptic targeting of
NMDA receptors in spinal neurons is preserved in the NR2B expression (Figure 1A) was easily detectable at
7 days and fully expressed by 10 days in vitro. Alsoexcitatory synapses on the dendritic shafts of hippo-
campal interneurons but differs from that present in hip- noted in these studies was a relative deficiency of PSD-
95, a lack of SAP-102, and an excess expression ofpocampal pyramidal neurons, expanding the molecular
differences between excitatory synapses on neurons NR2C in spinal neurons. Other proteins tested, aside
from those shown in Figure 1, that showed no significantwith or without dendritic spines.
differential expression between spinal and hippocampal
cultures included GRIP1 and GRIP2, Shank, NSF, andResults
PICK1.
Immunostaining of cultured ventral spinal neuronsNR2A and NR2B Target NMDA Receptors
with antibodies to NR1 (Figure 1F; S3C11-pan NR1) andto Synapses
all four NR2 receptor subunits (Figure 1G demonstratesPrevious work in our lab indicated that the lack of synap-
representative NR2A immunostaining) showed almosttic NMDA receptor clustering in spinal neurons was due
no clustering of NMDA receptor subunits in spinal neu-to the lack of expression of a crucial protein in postsyn-
rons after 1 or 2 weeks in vitro and minimal synapticaptic spinal dendrites (Mi et al., 2002). We began our
localization. Surprisingly, PSD-95 (Figure 1H) and Chap-current investigation by examining which postsynaptic
syn-110 (Figure 1I) showed excellent synaptic localiza-components, thought to be important for synaptic
tion in ventral spinal neurons in the absence of synapticNMDA receptor clustering in other systems, might be
NMDA receptor clustering. No synaptic staining wasabsent in ventral spinal neurons. We used immunoblots
seen with antibodies to SAP-102 or SAP-97 in ventralof spinal and hippocampal cultures to look for known
spinal neurons (data not shown). In contrast, in culturedcomponents of central postsynaptic densities (Sheng,
hippocampal neurons, clustered immunostaining was2001). Two important, reproducible deficiencies in cul-
seen with the NR1 (Figure 1B) and all NR2 subunit-tured spinal neurons compared to hippocampal neurons
specific antibodies (Figure 1C shows representativewere the severe reduction in the expression of the NMDA
receptor subunits NR2A and NR2B (Figure 1A). This dif- staining for NR2A) with the exception of the NR2C anti-
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Table 1. Transfection of Ventral Spinal Neurons with NR2A or NR2B Induces Synaptic Clustering of NMDA Receptors
A
Synaptic Clusters/Cell
Transfected with: NR1 GluR2
Control 1.5  0.5 11.9  3.5
NR1-1A (C2) 1.1  0.3 13.1  3.1
NR1-4A (C2) 1.6  0.5 10.6  2.2
NR2A 7.8  2.3** 13.6  3.0
NR2A plus APV/CNQX 6.9  1.7** 11.1  2.8
NR2B 8.9  4.1** 10.3  2.1
PSD-95 2.2  0.7 9.9  1.8
SAP-102 2.6  0.9 8.8  2.1
NR2A10 2.7  0.9 9.6  2.8
NR2C 1.6  0.6 15.0  4.2
NR2D 2.6  1.1 14.2  3.4
B
Mean Synaptic NR1
Transfected with: Synaptic NR1 Clusters Fluorescence Intensity
Control 2.2  1.1 —
NR2A 12.8  3.2** 2291  626
NR2A/D6 8.9  2.3** 1004  436***
NR2A/A6 3.6  1.5 —
NR2A/6 2.9  1.6 —
In panel (A), spinal neurons, grown for 3 days in vitro, were transfected with the indicated constructs (Control is pCMV-LacZ) plus a small
amount of HcRed (or eGFP) to identify the transfected cells, replated, and grown for 4 or 5 days, at which time they were fixed and stained
for synaptophysin plus GluR2 or NR1. The numbers expressed are the mean  SD of the mean of four separate experiments, except for
NR2C and NR2D, where three transfections were performed. All constructs except NR2C and NR2D were transfected concurrently. NR2C
and NR2D were transfected in a separate series of experiments with a concomitant positive control (NR2B) which showed the expected
induction of synaptic NR1 clusters (11.2  2.9 per cell). For each experiment, 20 to 25 consecutive, randomly selected HcRed (or eGFP)
positive neurons were chosen, and the number of synaptophysin-associated GluR2 or NR1 clusters on the selected neuron was counted in
one field (cell centered) at 100. The slides were blinded before counting. In panel (B), a second set of cultures were transfected with the
indicated constructs, and the number of synaptic NR1 clusters was determined along with the mean synaptic NR1 fluorescence intensity at
synapses deemed immunopositive for NR1. **p  0.001 compared with control in a paired comparison; ***p  0.02 compared to NR2A.
body, which did not show clustered staining in either NR2B transfection, while the number of synaptic GluR2
clusters was unchanged. Transfection with a mutant ofhippocampal or spinal neurons. The hippocampal NR2A
and NR2B synaptic accumulation was seen in the vast NR2A (NR2A10) that lacks the last ten amino acids of
its intracellular C terminus, the portion responsible formajority of neurons as soon as synaptic NR1 was de-
tected. Excellent synaptic localization was also seen in binding to the PDZ domains of PSD-95 and other MAGUK
proteins (Hung and Sheng, 2002), significantly reducedhippocampal neurons with antibodies to PSD-95 (Figure
1D) and Chapsyn-110 (Figure 1E), but not with antibod- the synaptic targeting of NR1 (Table 1). The NR2A- or
NR2B-induced accumulation of synaptic NMDA recep-ies to SAP-102 and SAP-97 (data not shown). At this
stage in culture, nearly all NMDA and PSD/Chapsyn tors occurred in the presence or absence of synaptic
activity, as APV (0.5 mM) plus CNQX (10 M) did notreceptor clusters in spinal and hippocampal neurons
are associated with presynaptic synaptophysin staining, affect the NR2A-induced accumulation of NR1. Overex-
pression of the NMDA subunits NR1-1A, containing theindicating that they are synaptic (Liao et al., 1999; Mi et
al., 2002). C2 cassette; NR1-4A, containing the C2 cassette;
NR2C; or NR2D in ventral spinal neurons had no effectGiven the deficiency of NR2A and NR2B expression
in cultured spinal neurons and their purported role in on the synaptic distribution of NR1, nor did overexpres-
sion of PSD-95 or SAP-102.synaptic NMDA receptor localization (Barria and Mali-
now, 2002), we transfected NR2B or NR2A into ventral In order to ensure that NR2A and NR2B were increas-
ing the surface, synaptic pool of NMDA receptors ratherspinal neurons 72 hr after plating, along with a small
amount of a construct encoding a fluorescent protein than simply aggregating a subsurface synaptic pool, we
transfected NR1-1A, containing an extracellular myc epi-to identify transfected cells, replated them onto glial
cells, and allowed them to grow for an additional 4–5 tope, along with NR2A and -B and looked at live surface
staining. As shown in Figure 2A and in the Supplementaldays. As shown in Table 1 and in the Supplemental Data
[http://www.neuron.org/cgi/content/full/44/2/335/DC1/], Data [http://www.neuron.org/cgi/content/full/44/2/335/
DC1/], when myc-NR1 is transfected into spinal neuronsexpression of either NR2A or NR2B in ventral spinal
neurons was able to reconstitute synaptic NMDA recep- alone there is a significant extrasynaptic surface accu-
mulation, typical of the extrasynaptic AMPA receptorstor accumulation as assayed by synaptic NR1 clustering.
Quantitatively, the mean number of synaptic NR1 clus- seen in these same cultures (Mammen et al., 1997). Like
extrasynaptic AMPA receptor clusters (Mammen et al.,ters increased nearly 5-fold (Table 1) with either NR2A or
Neuron
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Figure 2. Effect of NR2A on the Surface Expression of NR1
Ventral spinal neurons were transfected either with myc-tagged NR1-1A plus untagged NR2A or with myc-tagged NR1-1A plus control.
Following transfection, neurons were stained live with anti-myc to identify surface NR1 and then fixed, permeablized, and stained with anti-
GluR2/3 (A) to identify excitatory synapses. In (B) and (D), after transfecting with myc-NR1, neurons were stained live with anti-myc and then
fixed, permeablized, and stained for synaptophysin (Goat) plus either NR2D or NR2A (rabbit), respectively. In (C), the NR2D antibody was
blocked with NR2D transfected HEK293 extract as described in Experimental Procedures. In (E), live staining of myc-NR1 transfected neurons
was carried out with both anti-myc and anti-GluR1.
1997), the punctate appearance of extrasynaptic NR1 when myc-NR1-1A was cotransfected with NR2B but
not with NR2C, NR2D, or NR1-4A (see the Supplementalis a useful artifact of the bivalent anti-myc antibody and
is not seen when Fab fragments are used. Simultane- Data). These results suggest that extrasynaptic NMDA
receptors make it to the surface of dendrites and areously labeling the surface extrasynaptic myc-NR1 sub-
units with the mouse monoclonal anti-myc antibody re- part of a multimeric complex with NR2D. When NR2A
or NR2B are present, the receptor complex localizes tovealed colocalization with NR2D (Figure 2B, arrows) in
greater than 80% of the extrasynaptic myc-NR1 clusters the synapse. Further studies using immunoprecipitation
in cultured spinal neurons support this model (seeseen in a series of 34 transfected neurons from two
platings (546 of 627 extrasynaptic myc-NR1 clusters), below).
implying that they are part of a receptor complex. Little
colocalization of extrasynaptic myc-NR1 was seen with Are MAGUK Interactions Necessary and Sufficient
for Synaptic NMDA Receptor Targeting?either NR2A (Figure 2D) or NR2B (data not shown), per-
meablized GluR2/3 (Figure 2A), or surface GluR1 (Figure The results presented above show that the MAGUK-
interacting portions of NR2A and NR2B are necessary2E). In contrast, when myc-NR1 is transfected with un-
tagged NR2A, there is a significant synaptic accumula- for the synaptic targeting of NMDA receptors. The ques-
tion of why NR2C and NR2D, which have C-terminaltion of myc-NR1 (Figure 2A) and a decrease in extrasyn-
aptic clusters (see the Supplemental Data). The surface amino acid sequences similar (although not identical)
to NR2A and NR2B, are not sufficient to induce synapticsynaptic accumulation of myc-NR1 was also seen in
NR2A-transfected neurons stained live with an Fab anti- clustering of NMDA receptors was examined. First we
examined the immunoprecipitation of soluble, myc-myc antibody (10.6  5.9 surface synaptic myc-NR1
clusters per neuron [myc-NR1NR2A] versus 1.4 1.9 tagged, C-terminal tails of NR2A and NR2D with PSD-
95 in HEK293 cells (Figure 3A). We coexpressed a 30[myc-NR1 alone]; n  28 and 25 neurons, respectively),
eliminating the possibility that the bivalent antibody in- kDa C-terminal fragment of NR2A along with a 16 kDa
C-terminal fragment of NR2D and full-length PSD-95.duced the synaptic clusters. The same result was seen
NMDA Receptor Clustering in Spinal Neurons
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Figure 3. The Mechanism of NR2A-Induced Synaptic Clustering of NMDA Receptors
HEK293 cells were transfected with N-terminal myc-tagged versions of the C terminus of NR2A (30 kDa) or NR2D (16 kDa) with a 2:1 DNA
excess of NR2DCT along with PSD-95. PSD-95 was immunoprecipitated with mouse anti-PSD-95, and the total input and the immunoprecipitate
probed with rabbit anti-myc. Total represents 1/20 of the total material, while the IP represents 1/2 of the IP material. In (B), chimeric NR2A
and NR2D molecules are simultaneously coexpressed with PSD-95 in HEK293 cells. In this case, a 2:1 DNA excess of NR2A/D6 was used
compared with NR2D/A6. In these chimeras, the last six amino acids were switched. In (C), neurons transfected with the different NR2
constructs show representative synaptic NR1 distributions. Note the small synaptic clusters seen with NR2A/D6 (arrows) compared with native
NR2A. Scale bar, 4 m.
Both NR2 fragments contained N-terminal myc-tags. 1 (panel B), the NR2D/A6 chimera showed almost no
ability to induce the formation of synaptic NR1 clusters.Total NR2D was expressed in excess compared with
NR2A by manipulating DNA concentrations. Immuno- In contrast, NR2A/D6 did induce synaptic clustering of
NR1, but at a reduced rate compared with native NR2Aprecipitation of PSD-95 resulted in the coimmuno-
precipitation of both the NR2A and NR2D C-terminal and with a smaller mean synaptic receptor cluster size
compared to native NR2A. NR2A6, an NR2A mutantfragments, but a far greater excess of NR2A was immu-
noprecipitated even though it was underexpressed lacking its terminal six amino acids, showed no ability
to induce synaptic clusters of NR1, like the previouslycompared to NR2D. When the terminal six amino acids
of NR2A and -D were switched, creating chimeric C-ter- described deletion mutant NR2A10.
These data demonstrate that the C-terminal PDZ bind-minal fragments, the interaction between NR2A, NR2D,
and PSD-95 was reversed (Figure 3B). This implies that ing domain of NR2A is necessary for the synaptic clus-
tering of NMDA receptors and is more potent than athe C terminus of NR2D is less capable of interacting
with PSD-95 than that of NR2A and may explain part of similar motif present on NR2D. However, the data also
suggests that this PDZ binding motif is not sufficient forthe inability of NR2C and NR2D to induce the synaptic
targeting of NMDA receptors. A similar result was seen synaptic targeting, suggesting that an additional motif
present on NR2A and absent from NR2D is importantwith Chapsyn-110 (data not shown). Both PSD-95 and
Chapsyn-110 coimmunoprecipitations with NR2 C-ter- for synaptic targeting. Direct interactions between NR2A
and Narp, a potential AMPA receptor organizing mole-minal fragments from HEK293 cells were performed
twice with similar results. cule that interacts with the N terminus of AMPA recep-
tors, have not been demonstrated (see below), but thisIn a second set of experiments designed to test whether
the MAGUK binding domain of NR2A and -B was sufficient mode of interaction between NMDA receptors and an-
other extracellular organizing molecule(s) may be rele-for synaptic targeting, we transfected ventral spinal neu-
rons with chimeric NR2 subunits. The first, NR2A/D6, vant (see Discussion).
consisted of full-length NR2A whose final six amino
acids were switched to that of NR2D, while NR2D/A6 Narp Clusters NMDA Receptors in NR2A
Transfected Cellsconsisted of full-length NR2D whose final six amino
acids were switched to that of NR2A. These constructs, In addition to its effect on the synaptic targeting of
NMDA receptors, transfection of ventral spinal neuronsalong with GFP, were transfected into spinal neurons,
and the transfected neurons were assayed for the syn- with NR2A conferred on them a phenotype whereby
exogenous Narp could induce clusters of NMDA recep-aptic clustering of NR1. As shown in Figure 3C and Table
Neuron
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Table 2. Dominant-Negative Mutants of GluR2 and Stargazin Disrupt PSD-95 and NR2A-Mediated Synaptic Clustering of NMDA Receptors
in Spinal Neurons
A
Synaptic PSD-95 Synaptic Synaptic Synaptic Synaptic Stargazin
Transfected with: Cluster Chapsyn-110 GluR2 Clusters GluR1 Clusters Clusters (n  2)
Con (n  3) 13.1  3.7 12.3  3.1 12.8  2.5 9.7  2.8 14.2  4.3
GluR2CT (n  3) 4.3  1.9** 3.2  2.2** 3.7  1.4** 4.2  1.1** 4.3  2.1**
GluR1CT (n  3) 11.7  2.6 14.2  3.8 13.7  3.2 11.3  3.3 12.9  2.7
NR2ACT (n  3) 10.9  2.8 11.0  3.5 12.3  4.0
StargazinC (n  3) 4.7  1.9** 4.0  1.6** 9.9  2.7 8.6  2.0 —
StargazinCT (n  3) 3.2  1.3** 11.5  3.0
StargazinCT10 (n  3) 9.9  2.1 14.1  2.8
Stargazin (n  3) 14.3  3.9 15.6  2.3**
B
GluR2
Transfected with: NR1 Clusters Clusters
NR2A  Con. (n  6) 7.3  2.0 10.9  2.1
NR2A  GluR2CT (n  3) 2.8  1.3** 4.1  1.3**
NR2A  GluR1CT (n  3) 8.5  2.6 9.9  3.2
NR2A  stargazinC (n  3) 2.1  0.6** 9.8  2.1
NR2A  stargazinCT (n  3) 3.6  1.5*** 13.9  3.3
NR2A  stargazinCT10 (n  3) 6.1  1.4 10.7  2.0
NR2A  stargazin (n  3) 6.4  1.7 12.8  2.3
Ventral spinal neurons were transfected with the indicated constructs plus a small amount of HcRed (or eGFP) to identify the transfected
cells, replated, and grown for 4–5 days, at which time they were fixed and stained for PSD-95, GluR2, GluR1, Chapsyn-110, Stargazin, or NR1
along with synaptophysin. The numbers expressed are the mean  SD of the mean of three separate experiments, except for the NR2A plus
Control, which is the result of six experiments, and the stargazin, which is the result of two experiments. For each experiment, 20 to 25
consecutive, randomly selected HcRed/GFP-positive neurons were chosen, and the number of synaptic GluR1, GluR2, PSD-95, stargazin,
chapsyn, or NR1 clusters counted in one field (cell centered) at 100. The slides were blinded before counting. GluR1 clusters were determined
in cells stained live and thus represent surface clusters. The GluR1 synaptic clusters were counted only in neurons with at least one synaptic
GluR1 cluster, as is our usual routine, given that 40% of cultured spinal neurons do not express GluR1. **p  0.01 compared with control in
a paired comparison; ***p  0.05 compared with control in a paired comparison.
tors at sites of contact between Narp-expressing COS not the C terminus of GluR1 significantly reduced the
NR2A-induced accumulation of synaptic NR1 in spinalcells and the dendrites of spinal neurons (see the Sup-
plemental Data [http://www.neuron.org/cgi/content/full/ neurons. These results imply that AMPA and NMDA re-
ceptor targeting are coupled at synapses.44/2/335/DC1/]). Such a phenotype has already been
observed in untransfected hippocampal interneurons
(Mi et al., 2002). Stargazin Is Present Only at Excitatory Synapses
and Links Synaptic NMDA Receptors to AMPA
Receptors in Spinal NeuronsSynaptic NMDA Receptor Targeting Is Linked
to AMPA Receptor Targeting and Hippocampal Interneurons
Recent reports have shown that the tetraspanin stargazinSince previous work has shown that Narp does not inter-
act with NMDA receptors on spinal neurons or trans- and its related proteins can bind to both the MAGUK class
of proteins (through its C terminus) and to AMPA receptorsfected HEK293 cells (O’Brien et al., 1999, 2002), it is
likely that the NR2A-mediated aggregation of NMDA (via a site unrelated to the C terminus) providing a potential
cytoplasmic link between AMPA and NMDA receptorsreceptors seen in transfected spinal neurons is due to
the coaggregation of NMDA receptors with an unknown through MAGUK proteins (Chen et al., 2000; El-Husseini
et al., 2002). Moreover, these studies have also shownNarp-interacting postsynaptic protein or to the cyto-
plasmic coupling of NMDA receptors and AMPA recep- that a dominant-negative form of stargazin can be gener-
ated by deletion of its C-terminal PDZ binding domain,tors. To test whether the postsynaptic aggregating ma-
chinery of AMPA and NMDA receptors was coupled in the portion responsible for coupling stargazin to MAGUK
proteins (Chen et al., 2000). This mutant functions by dis-spinal dendrites, we transfected spinal neurons with the
C terminus of GluR2 (GluR2CT). Previously, we have rupting interactions between NMDA and AMPA receptors.
While Chen et al. and El-Husseini et al. demonstrated thatshown that the C terminus of GluR2 prevents the post-
synaptic aggregation of AMPA receptors without affect- stargazin mediated aggregation of AMPA-type glutamate
receptors at synapses in hippocampal pyramidal cells, weing the formation of excitatory synapses themselves
(Dong et al., 1997). As shown in Table 2 (panel A) and felt that it might potentially work in reverse fashion at the
AMPA predominant shaft synapses on spinal cord neuronsin the Supplemental Data (http://www.neuron.org/cgi/
content/full/44/2/335/DC1/), GluR2CT but not the C termi- and hippocampal interneurons.
As a first step in characterizing the role of stargazin innus of GluR1 or the C terminus of NR2A significantly de-
pressed the endogenous synaptic clustering of PSD-95 and synaptic glutamate receptor aggregation in these cultures,
we generated an antibody against the C terminus of ratChapsyn-110 in spinal neurons. Moreover, GluR2CT but
NMDA Receptor Clustering in Spinal Neurons
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Figure 4. Stargazin Expression in Cultured Ventral Spinal and Hippocampal Neurons
C-terminal anti-stargazin peptide antibody shows one distinct, appropriately sized, peptide-blockable band in immunoblots of spinal and
hippocampal neurons as well as in stargazin transfected HEK293 cells (H). This antibody shows peptide-blockable immunostaining that
colocalizes with GluR2 in cultured ventral spinal neurons (A and B) and hippocampal neurons ([C]–[E]; day 10 in vitro). No colocalization of
stargazin immunoreactivity was seen with GAD immunostaining (F).
stargazin, affinity purified it, and examined it on Western lated as the mean synaptic GluR2 immunofluorescence
per synapse (4877 /	 967 units per synapse [Control]blots of cultured spinal and hippocampal neurons. As
shown in Figure 4H, this antibody recognizes a protein versus 5239  1164 units per synapse [stargazinC];
mean  SD for 86 and 91 synapses, respectively, in tenof molecular weight 40 kDa, equally represented in both
hippocampal and spinal neurons grown for 12 days invitro. transfected neurons each). We also saw no change in the
intensity of surface synaptic GluR1 clusters in stargazinCThis is the same molecular weight as the signal from
HEK293 cells transfected with recombinant human star- transfected neurons (1622 298 units per synapse [Con-
trol] verus 2107  401 units per synapse [stargazinC];gazin. A second minor band at molecular weight 55 kDa,
seen in the cultured neurons, was not seen in stargazin- mean SD for 106 and 94 synapses, respectively, in ten
transfected, GluR1-expressing neurons each). Transfec-transfected HEK293 cells and was not blocked by preincu-
bation with stargazin peptide. When used for immuno- tion of full-length stargazin caused a modest increase in
the number of synaptic GluR2 clusters per transfectedstaining, the antibody showed peptide blockable signal
only at excitatory synapses, colocalizing with AMPA re- neuron (Table 2, panel B) and a slight increase in the mean
synaptic fluorescence intensity for GluR2 (4877  967ceptors in both ventral spinal neurons (Figures 4A and 4B)
and hippocampal (Figures 4C–4E) neurons. No stargazin units per synapse [Control] versus 5939 1319 units per
synapse [stargazin]; although this latter difference was notimmunosignal was seen to colocalize with the inhibitory
synaptic marker GAD (Figure 4F). Of note, in hippocampal statistically significant).
In addition to its effect on the endogenous synapticneurons, the stargazin signal was seen at excitatory syn-
apses on both the shafts of hippocampal interneurons clustering of PSD-95, the stargazin mutants also blocked
the NR2A-induced clustering of synaptic NMDA receptors(Figures 4C and 4D) and the spines of pyramidal cells
(Figure 4E). The appearance of stargazin at spinal syn- in ventral spinal neurons (Table 2) and decreased the ability
of exogenous Narp to cluster NMDA receptors on NR2A-apses shows the same dependence on intact AMPA re-
ceptor targeting as does PSD-95 and Chapsyn-110, as it transfected spinal neurons (see the Supplemental Data
[http://www.neuron.org/cgi/content/full/44/2/335/DC1/]).was disrupted by the dominant-negative GluR2 C-terminal
tail (Table 2, panel A). This latter observation suggests that stargazin plays a
similar role at Narp-induced receptor clusters and atWe transfected ventral spinal neurons with the domi-
nant-negative truncated form of human stargazin, lacking synaptic receptor clusters. In order to ensure that a
direct interaction between Narp, stargazin, and/or NR2Aits C-terminal four amino acids (designated stargazinC
as per Chen et al., 2000), along with GFP to identify trans- was not mediating synaptic NMDA receptor accumula-
tion in cultured spinal neurons, we coexpressed star-fected neurons. Chen et al. (2000) have shown that this
stargazin mutant fails to interact with endogenous MAGUK gazin and either Narp or NR2A in HEK293 cells. As
shown in the Supplemental Data, no evidence was seenproteins, thus disrupting synaptic interactions. Stargaz-
inC (as well as the soluble C terminus of stargazin) inhib- for coclustering or coimmunoprecipitation of Narp with
either stargazin or NR2A (coexpressed with NR1).ited the endogenous synaptic clustering of PSD-95 (and
Chapsyn-110), similar to the effect of overexpression of
the C terminus of GluR2 (Table 2, panel B). Endogenous Synaptic NMDA Receptor
Aggregation in Cultured Spinal NeuronsIn contrast to the effect of overexpressing the C terminus
of GluR2, stargazinC did not affect GluR2 (or GluR1) In order to investigate the discrepancy between our find-
ings of no clustered synaptic NMDA receptors in cul-synaptic clustering in ventral spinal neurons, either when
calculated as the number of synaptic clusters of GluR2 tured ventral spinal neurons and other reports sug-
gesting the existence of synaptic NMDA receptors (Kalbper transfected neuron (Table 2, panel B) or when calcu-
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Figure 5. NMDA Receptor Subunit Expres-
sion Associated with Synaptic Accumulation
In (A), immunoblots of the indicated synaptic
proteins were performed on high-density cul-
tured ventral spinal neurons after 7 or 14 days
in vitro or 2 days following a media switch to
either Neurobasal-B27 (B27) or Neurobasal-
B27 plus picrotoxin (100 M) and strychnine
(2 M) (B27/PS). The media switch occurred
between days 5 and 7 in vitro. Sister cultures
had total RNA extracted for Northern blots of
NR2A and NR2B mRNA levels (B) as de-
scribed in Experimental Procedures. The ar-
rowhead indicates the approximately 10–11
kb NR2A and NR2B transcripts, while the
arrow shows the position of the 28S ribo-
somal RNA. In (C), NMDA receptors from spi-
nal neurons grown for 7 days in control media
or grown for 5 days in control media and then
switched for 48 hr to B27 or B27 plus picro-
toxin and strychnine (B27/PS) were immuno-
precipitated using a combination of NR1C2
and NR1C2 polyclonal antibodies covalently
bound to Protein G (Seize-X, Pierce). The im-
munoprecipitate was probed with a series of
synaptic proteins. A 2-fold excess of Rabbit
IgG bound to the Seize-X beads served as control. Finally, surface proteins from 7 day control or B27 switched cultures were biotinylated
using LC-Biotin (Pierce) and immunoprecipitated with streptavidin beads and probed with the indicated synaptic proteins. All experiments in
Figure 5 were performed in triplicate, except the surface biotinylation experiment (5C), which was performed in duplicate.
et al., 1992; Konnerth et al., 1990; Ziskind-Conhaim tein expression seen after media switch was the appear-
ance of clustered synaptic NMDA receptors, consisting1990), we investigated conditions in our culture system
that could lead to these discrepant results. Since we of both NR1 and NR2A (Figure 6 and Supplemental Data
[http://www.neuron.org/cgi/content/full/44/2/335/DC1/]).had always placed an emphasis on keeping motor neu-
rons as healthy as possible, we routinely grew our cells in The effect of switching media could be antagonized by
increasing the amount of ambient excitatory synaptica very rich environment including chick embryo muscle
extract and serum. In order to investigate whether these activity in the cultures grown in defined media by includ-
ing picrotoxin and strychnine, GABA-A, and glycine re-conditions were related to our lack of clustered synaptic
NMDA receptors, perhaps by promoting excess synap- ceptor antagonist, respectively. As shown in Figures
5A and 6 and the Supplemental Data, the presence oftic activity, we switched our cultures after 5 days in vitro
from their normal enriched media to a more minimal picrotoxin and strychnine, which we have previously
shown increases excitatory synaptic activity in theseenvironment consisting of Neurobasal media with B27
supplements. As shown in Figure 5A, after 48 hr in this cultures (O’Brien et al., 1998), substantially abrogated
the increase in NR2A and NR2B associated with medianew media, both NR2A and NR2B protein levels could
be seen to substantially increase, far past the level seen switching and significantly diminished the number and
size of synaptic NMDA receptor clusters. It should beafter 2 weeks in standard media. Quantitative densitom-
etry showed a 6.8  1.2-fold increase in NR2B and an noted that the mean synaptic GluR2 immunofluores-
cence decreases with the same media switch that in-8.1  2.4-fold increase in NR2A (n  3).
Northern blots of total RNA from treated (B27) and creases NR1 immunofluorescence and NR2A and -B pro-
tein levels, implying that this is not a general trophic effect.untreated spinal neurons showed no change in NR2A
or NR2B mRNA levels. The high molecular weight bands In addition to the change in NMDA receptor subunit
expression noted with the switch in growth media, we(approximately 10–11 kB; arrowhead, Figure 5B) corre-
sponds to the size of the transcripts for NR2A and NR2B also observed a substantial change in the subunit com-
position of NMDA receptor complexes. As shown in Figurepreviously reported in the literature (Sasner and Buo-
nanno, 1996; Desai et al., 2002) and showed no change 5C, under basal conditions, immunoprecipitation of NR1
with a combination of NR1 C-terminal antibodies resultedin expression by densitometry in two separate experi-
ments comparing control to B27-treated cultures (ratio in little coimmunoprecipitation of NR2A but substantial
coimmunoprecipitation of NR2D. After switching toof B27/Control 0.92 0.06 for NR2B and 0.94 0.08 for
NR2A; n2). The second band (smear) at approximately 6 Neurobasal-B27, immunoprecipitation of NR1 resulted in
coimmunoprecipitation of NR2A and NR2B along withkb (directly above the 28S ribosomal RNA band) likely
represents a cross-reacting transcript or alternatively lesser amounts of NR2D. The amount of NR2C immuno-
precipitated with NR1 seemed unaffected by mediaspliced transcript. It also showed no increase in level
with media switch. Densitometry scanning of GAPDH change. These data are consistent with the results of
immunostaining of extrasynaptic receptors seen in Fig-showed that the same amount of total RNA was run in
each lane. ure 2, where extrasynaptic NR1 subunits (seen in standard
culture conditions) appeared to be complexed withAssociated with the increase in NR2A and NR2B pro-
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Figure 6. Ventral Spinal Neurons Demonstrate Synaptic NMDA Receptors after Switch to Defined Media
Ventral spinal neurons were grown for 5 days in standard growth media and then switched for 48 hr to either fresh growth media (Control),
B27 media, or B27 media plus picrotoxin (100 M) and strychnine (2 M). Other cultures were switched to B27 after first being transfected
with stargazinC and GFP. Synaptic NR1 clusters are seen most robustly in neurons switched to B27 media but were also seen in B27 plus
picrotoxin and strychnine (B27/P  S) neurons. In the latter condition, the synaptic NR1 clusters (arrows) were smaller than those seen in
B27 alone. Also noted in neurons grown in B27 media was a close correlation of NR1 with NR2A staining (B).
NR2D but not NR2A. Also consistent with the results of 335/DC1/]). The ability of these same NarpN transfected
axons to cluster the inhibitory synapse-specific postsyn-prior immunocytochemistry, surface biotinylation exper-
iments (Figure 5C) showed that surface NR1 expression aptic protein gephyrin is unaffected.
changes only marginally with the switch from culture
conditions that promote a largely extrasynaptic popula- NMDA Receptor Aggregation in Hippocampal
Neuronstion of NMDA receptors to one that promotes to a largely
synaptic population. To examine whether the native synaptic targeting of
NMDA receptors in hippocampal neurons shares theIn order to show that the expression of NR2A and
NR2B was causally related to the synaptic clustering of features of NR2A-induced targeting in spinal neurons
and to reconcile our results with those of Chen et al.NMDA receptors observed with the switch in culture
conditions, we transfected a series of neurons after 5 (2000), we chose to examine the synaptic targeting of
NMDA receptors in hippocampal interneurons. Likedays in culture (prior to media switch) with both GFP
and the C-terminal tails of either NR1 (C2 and C2), spinal neurons, hippocampal interneurons (which are
largely GABAergic and identifiable by cytoplasmic GAD-NR2A, or NR2D. In addition, we also evaluated the effect
of the stargazin and GluR2CT dominant-negative mu- 65 staining in culture; Mi et al., 2002) cluster synaptic
glutamate receptors on their dendritic shafts. These syn-tants (see the Supplemental Data [http://www.neuron.
org/cgi/content/full/44/2/335/DC1/]). Under these condi- aptic clusters of AMPA- and NMDA-type glutamate re-
ceptors on interneurons can be disrupted by the domi-tions, the C-terminal tail of NR2A but not the C-terminal
tails of NR1 or NR2D was able to prevent the increase nant-negative Narp mutant NarpN, which diminishes the
secretion of Narp from presynaptic terminals (O’Brienin synaptic NMDA receptor clustering induced by media
switching. A similar effect was seen for the stargazin domi- et al., 1999; Mi et al., 2002). This contrasts with glutamate
receptor clustering seen on the dendritic spines of hip-nant-negative mutant (Figure 6A).
When the dominant-negative Narp mutant NarpN, pocampal pyramidal cells in culture which is Narp (and
NarpN) independent and developmentally deficient inwhich reduces the presynaptic secretion of endogenous
Narp (O’Brien et al., 2002), is transfected into presynap- AMPA receptors (Liao et al., 1999; Lissin et al., 1998).
We transfected hippocampal neurons with the C-ter-tic axons under conditions in which spinal neurons ex-
press synaptic AMPA and NMDA receptors, the ability minal truncated stargazin dominant-negative mutant
stargazinC on day 4 in vitro along with HcRed to iden-of presynaptic axons to cluster both AMPA and NMDA
receptors as well as PSD-95 is reduced (see the Supple- tify transfected cells, replated them onto cortical
astrocytes, and allowed them to grow an additional 5–7mental Data [http://www.neuron.org/cgi/content/full/44/2/
Neuron
344
Table 3. The Effect of StargazinC on GluR2 and NR1 Clustering in Hippocampal Neurons
GAD-65 GAD-65	
Transfected at
Replating with: GluR2 NR1 PSD-95 Stargazin GluR2 NR1 PSD-95 Stargazin
Control 13.6  2.2 11.3  2.2 — — — 17.6  3.8 — —
StargazinC 13.1  2.4 4.8  1.7** — — — 19.3  2.0 — —
StargazinCT10 15.9  3.2 9.5  1.9 — — — 19.1  2.4 — —
GluR2CT 5.7  1.8** 4.1  1.3** — — — 14.8  3.3 — —
Transfected on
Day 9 with:
Control 34.0  5.5 39.2  6.4 36.8  10.1 40.2  7.0 29.9  7.1 44.1  7.8 38.8  6.5 36.9  4.8
StargazinC 29.8  8.4 19.3  5.3** 16.4  7.5** — 16.2  5.1** 37.7  12.1 31.6  8.2 —
GluR2CT 18.3  8.5** 25.3  5.6** 21.1  4.4* 27.1  3.3** 17.4  3.8** 40.3  8.3 41.5  5.2 38.8  6.9
Hippocampal neurons were transfected with the indicated constructs plus a small amount of HcRed or GFP to identify the transfected cells,
replated, and grown for 5–7 days, at which time they were fixed and stained for GluR2 or NR1 (mouse) and GAD (rabbit). A similar series of
neurons were transfected on day 8 or 9 and examined on day 10–12. These neurons were stained either in the same manner described above
or with stargazin (rabbit) and GAD (mouse) or with PSD-95 (mouse) plus GAD (rabbit). The numbers expressed are the mean  SD of the
mean of three separate experiments. For each experiment, 20 to 25 consecutive, randomly selected HcRed/GFP-positive neurons (both GAD
and GAD	) were chosen and the number of GluR2, NR1, stargazin, or PSD-95 clusters counted in one field (cell centered) at 100. Cells that
had no clusters of GluR2 (approximately 20% of the GAD 65 neurons transfected with each of the three constructs) were not counted. The
slides were blinded before counting. AMPA receptor clusters were not counted on young GAD65	 neurons (presumptive pyramidal cells)
because it was difficult to be certain of discreet clustering of these receptors at this stage. Synaptic NR1 clustering was, however, robust at
this time. Neurons transfected with stargazinC were not stained for stargazin, because of antibody cross-reaction. **p  0.02 compared
with control using paired Student’s t test; *p  0.05.
days. Interneurons (identified by their blue cytoplasmic tor targeting reconstituted (as determined by NR1 immu-
nostaining) by the overexpression of these same sub-staining with the polyclonal GAD 65 antibody) showed
no change in AMPA receptor clusters but a significant units. Overexpression of NR2C, NR2D, NR1, PSD-95, or
SAP-102 had no effect on the synaptic targeting ofdecrease in NMDA receptor clusters when transfected
with stargazinC (Table 3; see also the Supplemental NMDA receptors. These results offer an explanation for
the lack of basal NMDA receptor clustering at synapsesData [http://www.neuron.org/cgi/content/full/44/2/335/
DC1/]). In contrast, neurons which were GAD 65 negative in ventral spinal neurons (O’Brien et al., 1997; Mi et
al., 2002) and make this system extremely useful forhad no change in the number of NMDA receptor clusters.
We also transfected more mature hippocampal neu- evaluating how NMDA receptors become aggregated at
synapses. The importance of the NR2 subunits in therons on day 9 in vitro, without replating, and examined
them 48–72 hr later, using permeablized GluR2, NR1, synaptic targeting of NMDA receptors has been pre-
viously demonstrated by Barria and Malinow (2002), whostargazin, and PSD-95 staining (Table 3). The data dem-
onstrate a differential effect of stargazin and GluR2 mu- showed that NR2A or NR2B aided the synaptic delivery
of cotransfected NR1 in hippocampal slice neurons. Thetants on glutamate receptor clustering in interneurons
versus pyramidal neurons. In interneurons, synaptic NR1 main difference between our observation and theirs is
that cultured ventral spinal neurons do not have endoge-clustering is dependent on stargazin and AMPA receptor
localization, determined by their respective dominant- nous synaptic NMDA receptors prior to transfection with
NR2A or NR2B, either physiologically (O’Brien et al.,negative mutants, whereas in pyramidal neurons synap-
tic NR1 localization is resistant to stargazinC and 1997) or immunohistochemically (O’Brien et al., 1997,
1998), while synaptic NMDA receptors are already pres-GluR2CT disruption. Furthermore, native stargazin im-
munostaining is disrupted by GluR2CT in interneurons, ent prior to transfection in hippocampal slice prepara-
tions. Therefore, our data show that NR2A and -B notwhile in pyramidal neurons GluR2CT had little effect on
stargazin localization, perhaps indicating that stargazin only facilitate synaptic insertion but can initiate it. More-
over, our results indicate that the synaptic targetingis more a scaffolding protein in these cells. Older neu-
rons were more resistant to the effects of the mutants motifs on NR2 involve both the extreme C terminus, the
site of the PDZ binding domain, and at least one otherthan younger neurons, possibly due to changes in recep-
tor turnover rates. The lack of change of PSD-95 clusters site. The last six amino acids of NR2A and NR2B are
identical and differ from NR2C and NR2D at two aminoin hippocampal pyramidal neurons transfected with any
of the constructs argues against a change in the number acids. These differences, although involving physically
similar amino acids, results in a significant alteration inof excitatory synapses per se.
the interaction with PSD-95 and Chapsyn-110. Pre-
viously, Mori et al. (1998) and Steigerwald et al. (2000)Discussion
found that C-terminal truncation mutants of NR2A and
-B decreased synaptic targeting of NMDA receptorsNR2A and -B Expression Cause Synaptic
Clustering of NMDA Receptors in vivo, while Sprengel et al. (1998) did not observe this.
The overlapping function and distribution of NR2A andIn this paper, we have shown that ventral spinal neurons,
deficient in the expression of the NMDA receptor sub- -B, both of which can direct synaptic targeting of NMDA
receptors, is possibly the explanation for the failure tounits NR2A and NR2B, can have synaptic NMDA recep-
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see effects of single mutants and underlines the impor- terneurons), and Choi et al. (2004) have shown NR2A
induction by neurotrophin 4/5 in cultured neurons. Thetance of in vitro systems for dissecting these effects.
Overexpression of PSD-95 did not increase the synaptic effect we see is possibly a result of both direct growth
factor action and alterations in synaptic activity due totargeting of NMDA receptors in spinal neurons grown
in any culture conditions. One explanation for this is the changing environment.
that PSD-95 and/or Chapsyn-110 may be expressed in
saturating concentrations under basal conditions. Un- NMDA Receptors Are Coupled to AMPA Receptors
like Barria and Malinow, we did not see a significant Our data indicate that synaptic NMDA receptor aggrega-
effect of synaptic activity on NR2A or -B mediated syn- tion is dependent on the integrity of the AMPA receptor
aptic targeting, likely reflecting differences in the char- system. As such, conditions that disrupt AMPA receptor
acteristics of the underlying cell types or possibly in the accumulation at excitatory synapses, such as overex-
levels of expression of the transfected construct. pression of the C terminus of GluR2, also disrupt the
The existence of a second motif on NR2A and NR2B synaptic accumulation of MAGUK proteins and associ-
necessary for synaptic targeting of NMDA receptors was ated NMDA receptors. Given that the C terminus of
suggested from the chimeric NR2A/D experiments. It is un- GluR2 likely plays a role in transport and surface local-
likely that this motif mediates the assembly of a multi- ization of AMPA receptors (Dong et al., 1997; Burette et
meric receptor complex, as our data clearly show that al., 2001; Sheng and Lee 2003) but not in any interaction
NR2D associates with NR1 in an extrasynaptic multi- with Narp (extracellular), stargazin (transmembrane), or
meric surface receptor complex. Moreover, we have PSD-95 (no proven interaction), its effect on NMDA re-
found no evidence that NR2A associates directly with ceptors is likely to be mediated purely through the failure
Narp or stargazin. Additional C-terminal or N-terminal of AMPA receptors to appear at excitatory synapses.
interactions seem the most attractive possibilities and The failure of the C terminus of GluR1 to affect AMPA
will be further explored using chimeric receptors. Recent receptor trafficking in spinal neurons is in contrast with
work with both Narp (O’Brien et al., 1998) and GluR2 results in hippocampal neurons where acute activity-
(Passafaro et al., 2003) has established the precedence induced synaptic redistribution of AMPA receptors (as
of extracellular determinants on glutamate receptors as seen in LTP) is mediated by GluR1, while constitutive
synaptic targeting motifs. synaptic redistribution is modulated by the C terminus
Finally, a recent report by Mu et al. (2003) showed of GluR2 and GluR3 (See Lee et al., 2004). Given that
that, in hippocampal neurons, the C2 cassette of NR1, acute activity-dependent redistribution of AMPA recep-
downregulated under basal conditions, leads to synap- tors is difficult to demonstrate in neurons with predomi-
tic accumulation of NMDA receptors when overex- nantly shaft synapses (McBain et al., 1999), it may be
pressed or upregulated due to synaptic blockade. We that spinal neurons and hippocampal interneurons lack
have found that NR1 subunits expressing this cassette the GluR1-mediated component of receptor cycling. Al-
are plentiful under basal conditions in cultured ventral ternatively, the activity-induced cycling of GluR1 may
spinal neurons, conditions in which synaptic NMDA re- modulate GluR1 accumulation but not that of other
ceptors are lacking. Moreover, overexpression of NR1- AMPA or NMDA receptor subunits.
4A, which contains the C2 cassette, does not increase Previously, we have shown that the dominant-nega-
synaptic NMDA receptor targeting. These and other tive Narp mutant NarpN disrupted AMPA receptor ag-
studies underline the important differences between spi- gregation at hippocampal interneuron synapses and
nal and hippocampal neurons, a difference we believe also disrupted synaptic NMDA receptor accumulation.
arises from the shaft-predominant synapses in the spi- Given that Narp has no endogenous ability to interact
nal neurons and the spine-predominant synapses in hip- with NMDA receptors (O’Brien et al., 1999; Mi et al.,
pocampal neurons. 2002), we felt that this indicated that the failure of NMDA
receptors to aggregate at synapses was secondary to
the failure of Narp-dependent AMPA receptor aggrega-Culture Conditions Alter Synaptic NMDA
Receptor Accumulation tion. The same effect of NarpN on AMPA and NMDA
receptor clustering is seen in spinal neurons grown inSwitching spinal neurons from a growth factor-rich envi-
ronment to a defined media caused both the appearance defined media. This conclusion is further strengthened
by the observation that stargazin mutants disrupt PSD-of NR2A and NR2B and the synaptic accumulation of
NMDA receptors, events that our dominant-negative 95/NMDA receptor aggregation without affecting AMPA
receptor aggregation in spinal neurons and hippocam-constructs suggest are causally related. Associated with
this is a decrease in GluR1 expression and a diminution pal interneurons. That NarpN, stargazinC, and GluR2CT
are not toxic is shown by the lack of effect of theseof synaptic AMPA receptor accumulation. The NR2A or
NR2B accumulation occurred in the absence of any mutants on NMDA receptor aggregation in hippocampal
pyramidal cells (see below).change in mRNA expression, reminiscent of the effect
of synaptic activity on synaptic AMPA receptor accumu- Our data would also argue against a system in which
NMDA receptors are guided by AMPA receptors onlylation (O’Brien et al., 1998), and possibly implicates pro-
tein turnover as the causative mechanism for subunit through their intracellular transport and surface insertion
phase. Using epitope-tagged NR1, we saw no influenceexpression levels. Precedents for growth factor effects
on glutamate receptors exist. Rutherford et al. (1998) of GluR2CT on surface NR1 insertion and observed that
NR1 surface expression (defined by surface biotinyla-found that BDNF significantly modified AMPA receptor-
mediated quantal amplitude in hippocampal pyramidal tion) is quite robust even when the receptors are almost
exclusively extrasynaptic. Finally, the ability of Narp trans-neurons (with an opposite effect on hippocampal in-
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fected COS cells to aggregate NMDA receptors on NR2A or a similar molecule. Given the dual expression of PSD-
95 and Chapsyn-110 at spinal synapses, it is likely thattransfected spinal neurons (and hippocampal interneu-
rons; Mi et al., 2002) demonstrates the sufficiency of double knockouts will be necessary to completely evalu-
ate the role of MAGUK proteins in the synaptic organiza-Narp alone for this process. Since Narp does not aggre-
gate NMDA receptors directly, even when coexpressed tion of spinal neurons.
on the same HEK293 cell (Mi et al., 2002, and the Supple-
mental Data [http://www.neuron.org/cgi/content/full/44/2/ Hippocampal Interneurons Differ from Pyramidal
335/DC1/]), a direct linkage between AMPA receptors Neurons in their Mechanism of Synaptic
and NMDA receptors, independent of additional presyn- NMDA Receptor Targeting
aptic aggregating molecule, appears to be the best ex- Our current data again emphasize the differences be-
planation. tween excitatory synapse formation on hippocampal in-
Experiments using chimeric NR2A/NR2D molecules terneurons and pyramidal neurons. In addition to differ-
suggest an additional NR2A- or NR2B-mediated link to ences in their neurotransmitter phenotype (interneurons
excitatory synapses through a motif located outside the are predominantly inhibitory while pyramidal cells are
extreme C terminus. Whether this additional NR2A or predominantly excitatory), they also differ in the manner
NR2B motif facilitates AMPA-NMDA receptor interac- in which they receive excitatory synapses on their den-
tions or serves as a link to an additional synaptic organiz- drites. Spinal cord neurons share many of the features
ing molecule(s) will await further work. of hippocampal interneurons, although their neurotrans-
mitter phenotype is more variable. Hippocampal interneur-
ons and spinal neurons receive excitatory synapses di-MAGUK Protein and Stargazin Expression
in Cultured Ventral Spinal Neurons rectly onto their dendritic shafts, while pyramidal cells
receive excitatory synapses onto their dendritic spines.The mechanism of linkage between NMDA and AMPA
receptors appears to be dependent either on stargazin In addition to differences in morphology, synaptic pro-
teins also appear to be differentially expressed at excit-itself, or a closely related molecule (Tomita et al., 2003),
and a MAGUK protein. Both the soluble stargazin C-ter- atory spine and shaft synapses. Examples include Syn-
GAP, citron, bundled actin filaments, and Narp (Allisonminal tail and the transmembrane component of star-
gazin without its C-terminal tail act in a dominant-nega- et al., 1998; Zhang et al., 1999; Mi et al., 2002). Even
NMDA- and AMPA-type glutamate receptor subunits aretive fashion toward NMDA receptor and MAGUK protein
synaptic aggregation in spinal neurons and hippocam- themselves expressed differentially at these two types
of excitatory synapses (O’Brien et al., 1997; Allison etpal interneurons. This indicates that it is not simply a
molecule that shares the C-terminal PDZ binding motif al., 1998; Gomperts et al., 1998; Lissin et al., 1998; Rao
et al., 1998; Liao et al., 1999). Functionally, excitatoryof stargazin that is responsible for coupling the receptor
types but a molecule which shares the AMPA receptor- synapses on spines and shafts also differ. Dendritic
shaft synapses in hippocampal interneurons have beeninteracting domain of stargazin as well. Immunostaining
with stargazin-specific antiserum indicates that star- resistant to LTP induction (McBain et al., 1999) and un-
dergo homeostatic scaling in a manner different fromgazin is in place at AMPA-predominant synapses in spi-
nal and hippocampal neurons, extending the prior find- pyramidal cells (Rutherford et al., 1998).
Our observations of a fairly uniform accumulation ofings of Sharp et al. (2001). The PDZ binding sites of NR2A
and NR2B (IESDV) likely bind to PDZ 1 and -2 of PSD- synaptic NMDA receptor clusters in hippocampal in-
terneurons are somewhat at variance with those of Nyiri95 (Hung and Sheng, 2002). The different PDZ binding
domain of stargazin (RTTPV) is similar to that of neuroli- et al. (2003), who found significant differences in synap-
tic NMDA receptor accumulation between differentgin (TTPV) and likely binds to PDZ 3 of PSD-95. As such,
overexpression of the C-terminal tail of NR2A and NR2B classes of interneurons in vivo. Given the differences
between our in vitro system and their in vivo system,would not be expected to affect the synaptic targeting
of PSD-95 or Chapsyn-110, which is indeed the case the source of these differences could be either the selec-
tion of a single class of interneurons for culture related(Table 2).
Given the nonsynaptic localization of NMDA receptors to the staged birth of interneuron classes in vivo (E18–21)
or could reflect a leavening effect of tissue culture condi-in cultured ventral spinal neurons, we were initially sur-
prised to see synaptic clustering of PSD-95 and Chap- tions.
Consistent with the ongoing emphasis on the differ-syn-110/PSD-93 under basal conditions. However, given
the presence of stargazin at these synapses under basal ences between interneurons and pyramidal cells, our
results contrast with those of Chen et al. (2000), whoconditions, it is not, in retrospect, surprising to find colo-
calized MAGUK proteins. Other investigators have es- found that the dominant-negative mutant stargazinC
only affected AMPA receptor clustering in hippocampaltablished an interaction between stargazin and PDZ do-
main-containing proteins though stargazin’s C terminus neurons. We feel that this difference is likely the result
of the predominance of pyramidal cells (
85%) in hippo-(Schnell et al., 2002). The recent finding that Chapsyn-
110/PSD-93 knockout mice show impaired synaptic campal cultures. We also found no effect of stargazinC
on NMDA receptor clustering in these cells. It will be ofNMDA receptor expression but normal AMPA receptor
expression (Tao et al., 2003) is in agreement with our great interest to see if the differences between these
two cell types are due to relative mobility issues betweenobservations. Whether Chapsyn-110 or PSD-95 serve
identical/overlapping functions or have subtly different AMPA and NMDA receptors, perhaps mediated by the
pattern of MUGAK protein expression.functions or distributions is not clear. Our data suggest
that the synaptic localization of both is tied to stargazin A useful model of synaptic glutamate receptor local-
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ondary antibodies (Jackson Immunochemicals, West Grove, PA)ization in spinal neurons and hippocampal interneurons
were then added at 10 g/ml for 1 hr at room temperature as indi-would involve AMPA receptor transport/synaptic deliv-
cated. Coverslips were mounted in ProLong (Molecular Probes).ery mediated by cytoplasmic factors that bind to the C
Live immunostaining prior to fixation was carried out for 30 min at
terminus of GluR2 (and GluR3). These receptors could 37C in MEM plus APV (100 M) and CNQX (10 M).
then be stabilized at the synapse (once inserted) by In experiments looking at the colocalization of NR1 and NR2D or
NR2A immunosignal in extrasynaptic receptors, myc-NR1 trans-Narp. Stargazin would play a bridge role to synaptic
fected neurons were stained live with mouse monoclonal anti-myc,NMDA receptors and less of a role in synaptic AMPA
fixed in sequential paraformaldehyde and methanol, and thenreceptor localization. In hippocampal pyramidal cells,
stained with either polyclonal NR2A or NR2D and goat anti-synapto-cytoplasmic AMPA receptor interactions are still impor-
physin (Santa Cruz). In order to perform a block of NR2D staining,
tant, but stargazin assumes a more significant role in HEK293 cells were transfected with NR2D (or NR2A) along with NR1.
the synaptic delivery of AMPA receptors and less of a The cells were then surface biotinylated, solublized, and the surface-
labeled proteins streptavidin immunoprecipitated. The labeledrole in synaptic NMDA receptor localization. Narp is
beads from NR2D transfected cells were incubated with the NR2Dabsent at these synapses, although other synaptic or-
antisera in PBS for 1 hr at 4 and then used directly to stain cells.ganizing molecules that bind directly to AMPA receptors
NR1/NR2A transfected HEK293 cells served as a negative controlmay be present (Xu et al., 2003; Passafaro et al., 2003).
for the NR2D antibody to ensure that we were specifically ab-
Synaptic aggregating molecules such as the neurexins sorbing antibody.
and ephrins could couple directly to PSD-95 without
an AMPA receptor bridge, allowing them to aggregate Clustering Assay
NMDA receptors without an AMPA receptor intermedi- At variable times after transfection, neuronal coverslips were fixed
and stained as described above. In most cases, the number ofary (Gerlai, 2001; Scheiffele et al., 2000). These would be
synaptic clusters of a given protein was assayed by combiningideally situated to regulate spiny synapses, but whether
rabbit and mouse antibodies to synaptic proteins (i.e., GluR1 orthey are differentially regulated at spine and shaft syn-
NR1) with mouse or rabbit synaptophysin antibodies, respectively.apses has not been established.
The technical details of the assay, its blinding, and how it is scored
have been published (OBrien et al., 2002). In all cases, except for
Experimental Procedures assays of quantitative synaptic immunofluorescence, the numbers
expressed are the mean  SD of the mean of three or four separate
Cell Culture experiments, each run with a control condition. The semiquantitative
Low- and high-density ventral spinal neurons (from E15 rat embryos) estimation of extrasynaptic clusters was described in Mammen et
and hippocampal neurons (from E18–20 rat embryos) were isolated al. (1997). Quantitative estimates of synaptic NR1 and GluR2 accu-
and grown as described (O’Brien et al., 1997) on a bed of preplated mulation were performed as described (O’Brien et al., 1999) and in
cortical glia. Growth media consisted of MEM plus N2 supplements each case involved at least 200 randomly chosen synapses from
as well as E18 chick hindlimb extract at 15 g/ml (Henderson et al., 20 neurons over two platings unless otherwise specified. If the neu-
1993; O’Brien et al., 1997) and 3% horse serum. Cultures were ron had a mixture of synapses that appeared both immunopositive
maintained from 7 to 17 days, depending on the experimental para- and immunonegative (as in the case of NR2A/D6 transfection) only
digm, with every other day feedings of 1/3 the culture volume. In the synapses that were deemed immunopositive were analyzed.
some cultures, growth media was switched after 5 days to a media Thus, this technique places an upper limit on the mean synaptic
consisting of Neurobasal (Invitrogen) plus B27 supplements (1:50). immunofluorescence. Experiments in hippocampal neurons involv-
This media was supplemented with glutamax 1:200 and was condi- ing GAD-positive and -negative neurons did not use synaptic clus-
tioned by a monolayer of glia for 8 hr prior to use. ters per se, given the lack of chromophores. The efficacy of NarpN
and control transfected axons to cluster GluR2, PSD-95, and geph-
Constructs yrin on untransfected postsynaptic dendrites was assayed as de-
See the Supplemental Data (http://www.neuron.org/cgi/content/ scribed in O’Brien at al. (2002). For this latter assay, a minimum of
full/44/2/335/DC1/). 80 transfected axons (control and NarpN) were examined for each
postsynaptic protein assayed over three platings.
Neuronal Transfections
Spinal and hippocampal neurons were routinely transfected using Antibodies
lipofectamine 2000 (Invitrogen) after 3 days in vitro by combining 1 g A C-terminal stargazin antibody was raised in rabbits by immunizing
of total DNA with 2 l of lipofectamine 2000 in a final volume of 70 them with the rat stargazin C-terminal peptide KDSKDSLHAN
l. This solution was added to one well in a 12-well dish containing TANRRTTPV coupled to albumin. The resultant serum was purified
30,000 neurons and 800 l of MEM for 90 min at 37C. The cells on an affinity column of the same peptide coupled to thyroglobulin.
were then rinsed in MEM and their original media added back. Four The affinity-purified antibody was used at 1 g/ml for immunoblots
hours after transfection, the cells in each well were trypsinized off and at 2g/ml for immunostaining. Antibodies to the NMDA receptor
the plate with 100 l of 0.025% trypsin, mixed with 1 ml of fresh subunit NR2C was obtained from Molecular Probes and used at
growth media, and added to a fresh well containing a glial-coated 1:300 for immunoblots and staining, while the NR2D antibody was
coverslip. After 12 hr, the media was completely changed, and the purchased from Santa Cruz and used at 1:100 for staining and 1:200
cells were then fed regularly for 4–7 days until assayed. Additional for immunoblots. NR2A antibodies were obtained from Upstate Bio-
hippocampal cultures were transfected after 8 or 9 days in vitro and technology (polyclonal #06313), raised against amino acids 1260–
examined (without replating) after an additional 48–72 hr. Similarly, 1460 of mouse NR2A and used in immunoblots at 1:600 and for
in some cases, spinal neurons were transfected with various con- immunostaining at 1:300, and from Chemicon (MAB5216), raised
structs at 5 days in vitro without replating, immediately prior to against amino acids 1099–1213 of human NR2A. The Chemicon NR2A
switching the growth media to Neurobasal plus B27. antibody was used at 3 g/ml for immunoblots. NR2B antibodies were
obtained from Transduction Labs (monoclonal #610416), raised against
rat amino acids 892–1051 and used at 1 g/ml for immunoblots andImmunohistochemistry
Neuronal cultures were fixed in 4% paraformaldehyde, 4% sucrose 2 g/ml for immunostaining and a rat extreme C-terminal peptide
polyclonal anti NR2B antibody (Lau and Huganir 1995) used at 2 g/in PBS for 5 min, transferred to methanol at 	20 for an additional
15 min, permeablized in 0.1% Triton X-100 for 10 s, and then rinsed ml for immunoblots and 5g/ml for immunostaining. NR1 antibodies
consisted of the C2 cassette-specific polyclonal antibody from Phar-twice in PBS. Coverslips were then blocked in 10% goat serum at
room temperature for 1 hr and incubated with primary antibodies mingen (#690KC; used at 2 g/ml for immunoblots) and the C2
cassette-specific polyclonal antibody from Upstate Biotechnologyfor 24 hr at 4C. Rhodamine, AMCA, or fluorescein-conjugated sec-
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(#06311: used at 1g/ml for immunoblots). For NR1 immunostaining, Surface Biotinylation
Cell surface proteins were biotinylated and streptavidin immunopre-we used the S3C11 pan NR1 monoclonal. The PSD-95 monoclonal
antibody was obtained from Transduction Labs (#610495) and used cipitated as described in Mammen et al. (1997). Equivalent volumes
of material from control and Neurobasal B27-treated cultures wereat 1 g/ml for immunoblots and at 5 g/ml for immunostaining. We
also used the anti PSD-95 monoclonal from Upstate (#05-494) with run, each lane representing 1/10 of the total surface material from
a 10 cm dish of neurons.similar results.
The Chapsyn-110 polyclonal was purchased from USBiological
and used at 1:300 (immunoblots) and 1:200 (immunostaining). Anti- Northern Blots
High-density 10 cm dishes of spinal neurons were grown in standardbodies against the myc epitope, GluR2 (monoclonal), GluR2/3 (poly-
clonal), tubulin, synaptophysin (mouse and rabbit), and GAD (mouse media or switched for 48 hr to Neurobasal media plus B27 supple-
ments. Total RNA was extracted using Totally RNA (Ambion) andand rabbit) have been described in our previous publications
(O’Brien et al., 1997, 2002), as have the SAP-97 (Rumbaugh et al., processed for Northern blotting as described (O’Brien et al., 1998),
running 5 g of RNA per lane. Probes consisting of a 1.2 kb Pst12003) and SAP-102 antibodies (Lau et al., 1996).
fragment of rat NR2A and an 800 bp PCR fragment (3677–4470) of
rat NR2B were labeled with 32P by random priming. Blots were ex-Coimmunoprecipitation Experiments: HEK293 Cells
posed to a phosphorimager for 9 days and quantitated using Im-HEK293 cells were transfected with N-terminal myc-tagged versions
ageQuant. Blots were stripped and reprobed with a 500 bp fragmentof the C terminus of NR2A (30 kDa), NR2D (16 kDa), and PSD-
of rat GAPDH.95 with a DNA ratio of 1, 2, 1, respectively. Additional cells were
transfected with the C-terminal constructs NR2A/D6, NR2D/A6, and
AcknowledgmentsPSD-95 in a 2, 1, 1 DNA ratio. A similar set of experiments was done
using Chapsyn-110 rather than PSD-95. The cells were solublized
Supported by NIH grants R01NS037694 (R.J.O.), the Howard Hughesin PBS plus 1% Triton X-100 plus protease inhibitors (Pierce). PSD-
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Research (R.J.O. and R.L.H.).followed by protein A/G beads (Pierce), washed twice with PBS plus
0.2% Triton X-100, and once in PBS plus 200 mM NACL. The total
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